Literature DB >> 18836774

Computational detection of deleterious SNPs and their effect on sequence and structural level of the VHL gene.

R Rajasekaran1, C Sudandiradoss, C George Priya Doss, Anshuman Singh, Rao Sethumadhavan.   

Abstract

In this work we have analyzed the genetic variation that can alter the expression and the function of the VHL gene using computational methods. Of 110 single nucleotide polymorphisms (SNPs), 33 were found to be nonsynonymous (nsSNPs) and 23 SNPs were found in untranslated regions. Of the 33 nsSNPs investigated, 36.3% were found to be deleterious by both SIFT and PolyPhen servers. An untranslated region (UTR) resource tool suggested that two SNPs in the 5' UTR region and six SNPs in the 3' UTR region might change the protein expression levels. It was found by both SIFT and PolyPhen servers that a mutation from histidine to arginine at position 115 of the native protein of the VHL gene was most deleterious. A structural analysis of this mutated protein and the native protein was performed and had a root mean square deviation (RMSD) of 2.78 A. Based on this work, we propose that the nsSNP with a SNPid of rs5030812 is an important candidate for the cause of von Hippel-Lindau syndrome via the VHL gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18836774     DOI: 10.1007/s00335-008-9143-8

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  59 in total

1.  Identification and in silico analysis of functional SNPs of the BRCA1 gene.

Authors:  R Rajasekaran; C Sudandiradoss; C George Priya Doss; Rao Sethumadhavan
Journal:  Genomics       Date:  2007-08-27       Impact factor: 5.736

2.  A DNA polymorphism discovery resource for research on human genetic variation.

Authors:  F S Collins; L D Brooks; A Chakravarti
Journal:  Genome Res       Date:  1998-12       Impact factor: 9.043

3.  Three novel mutations in the Von Hippel-Lindau tumour suppressor gene in Italian patients.

Authors:  P Mandich; M Montera; E Bellone; A Trojani; S Daniele; F Ajmar
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

4.  Germline mutations detected in the von Hippel-Lindau disease tumor suppressor gene by Southern blot and direct genomic DNA sequencing.

Authors:  C Li; G Weber; P Ekman; J Lagercrantz; B J Norlen; G Akerström; M Nordenskjöld; U S Bergerheim
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

5.  Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.

Authors:  B Zbar; T Kishida; F Chen; L Schmidt; E R Maher; F M Richards; P A Crossey; A R Webster; N A Affara; M A Ferguson-Smith; H Brauch; D Glavac; H P Neumann; S Tisherman; J J Mulvihill; D J Gross; T Shuin; J Whaley; B Seizinger; N Kley; S Olschwang; C Boisson; S Richard; C H Lips; M Lerman
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

6.  Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.

Authors:  S Olschwang; S Richard; C Boisson; S Giraud; P Laurent-Puig; F Resche; G Thomas
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

7.  Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia.

Authors:  Yves Pastore; Katerina Jedlickova; Yongli Guan; Enli Liu; James Fahner; Henrik Hasle; Jaroslav F Prchal; Josef T Prchal
Journal:  Am J Hum Genet       Date:  2003-07-03       Impact factor: 11.025

Review 8.  Molecular basis of the VHL hereditary cancer syndrome.

Authors:  William G Kaelin
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

9.  Von Hippel-Lindau disease: a genetic study.

Authors:  E R Maher; L Iselius; J R Yates; M Littler; C Benjamin; R Harris; J Sampson; A Williams; M A Ferguson-Smith; N Morton
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

10.  Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.

Authors:  E R Maher; A R Webster; F M Richards; J S Green; P A Crossey; S J Payne; A T Moore
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.